TherapeuticsMD, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was USD 28.56 million compared to USD 23 million a year ago. Net income was USD 112.28 million compared to net loss of USD 42.65 million a year ago. Basic earnings per share from continuing operations was USD 12.83 compared to basic loss per share from continuing operations of USD 5.41 a year ago. Diluted earnings per share from continuing operations was USD 12.39 compared to diluted loss per share from continuing operations of USD 5.41 a year ago.
For the six months, revenue was USD 47.89 million compared to USD 42.87 million a year ago. Net income was USD 63.26 million compared to net loss of USD 82.04 million a year ago. Basic earnings per share from continuing operations was USD 7.29 compared to basic loss per share from continuing operations of USD 11.06 a year ago. Diluted earnings per share from continuing operations was USD 7.05 compared to diluted loss per share from continuing operations of USD 11.06 a year ago.